<unk> (ophthalmic) is an anti-inflammatory, calcineurin inhibitor and immune suppressant agent that is FDA approved for the treatment of increase tear production in patients whose tear production is presumed to be suppressed due to ocular inflammation associated with keratoconjunctivitis sicca.   Common adverse reactions include burning sensation in eye.
Cyclosporine 
Sirolimus
Tacrolimus 
Mycophenolate
Temsirolimus
Mycophenolate sodium
Rituximab
Lenalidomide